R1 RCM — Investor Presentation (June 2020)
34 slides from R1 RCM's investor presentation, Jun 3, 2020
Slide 1: Investor Presentation June 3, 2020
Exhibit 99.1 Investor Presentation June 3, 2020
Slide 2: Forward-Looking Statements and Non-GAAP Financial Measures
Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute “forward-looking statements,” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future, not pa
Slide 3: R1 Investment Highlights
R1 Investment Highlights Strong Profit Unique Large Multiple Growth Trajectory Value Market Drivers with High Underpinned by Proposition Opportunity Recurring Revenue Tech Investment Operating Model $110B 14% $168M Robust & Proven Acute & Physician RCM Average Quarterly Adjusted EBITDA in 2019 Scale
Slide 4: Significant Improvements for Integrated Health Systems
Significant Improvements for Integrated Health Systems NEED VALUE ADD RESULTS Growing • Lower costs pressure to run revenue cycle We plug into • Faster collections more efficiently health providers’ • Higher revenue existing • Higher patient satisfaction IT systems OPERATING MODEL Proprietary Experi
Slide 5: Comprehensive Revenue Cycle Capabilities for Providers
Comprehensive Revenue Cycle Capabilities for Providers Care Settings Emergency Physician Acute Post-Acute Revenue Cycle Phases Order to Intake Care to Claim Claim to Payment Solutions address the full spectrum of needs and Payment Models operations Fee-for-service Patient Self-pay Value-based Transf
Slide 6: Acquisition of RevWorks
Acquisition of RevWorks ▪ Further establishes R1 footprint across acute and ambulatory markets Strategic ▪ Valuable commercial partner in Cerner, speaking to R1’s best-in-class capabilities Rationale ▪ Access to high quality experienced team to support scaled growth ▪ Supports our commitment to R1 t
Slide 7: Partnership with Cerner
Partnership with Cerner A B C Deal and Marketing Technology Product Collaboration Integration Collaboration ▪ Cerner will offer R1’s ▪ Enhanced technology ▪ Collaboration and integration of capabilities to clients across its integration will streamline R1 digital patient experience broad nationwide
Slide 8: SCI Transaction Rationale
SCI Transaction Rationale ▪ Delivers most comprehensive solution to drive patient engagement for health systems Enhances Growth ▪ Expands R1 addressable market and supports commercialization of PX modular offering Trajectory ▪ Further differentiates R1’s value proposition in end-to-end opportunities
Slide 9: Industry's Only Integrated Pre-Service SaaS Workflow
Industry’s Only Integrated Pre-Service SaaS Workflow Automated Choreography Across Any Provider Care Setting SCI Core Product Offerings 1 2 3 4 Provider Network Schedule Digital Patient Intake Experience (PNX) Maximizer Experience (DPX) Analytics Capture Confirm Schedule Obtain Maintain Outpatient F
Slide 10: Industry's Only Integrated Pre-Service SaaS Workflow
Industry’s Only Integrated Pre-Service SaaS Workflow Automated Choreography Across Any Provider Care Setting Capture Confirm Schedule Obtain Maintain Outpatient Financial Viability Order Optimally Pre-Service Case Arrival, Update and Demand of Case Utilize Capacity Preparations Follow Up Search and
Slide 11: R1 Strategic Priorities with SCI Acquisition
R1 Strategic Priorities with SCI Acquisition 1 2 3 Solidify and Extend Our Integrate R1 and SCI Lead as the Most Enable High-Performing Technology to Transform Comprehensive Digital Marketplace for Scheduling and Pre- Patient Experience Healthcare Services Registration Process Solution in the Market
Slide 12: Integrate R1 and SCI Technology to Transform Scheduling and Pre-Registration
Integrate R1 and SCI Technology to Transform Scheduling and 1 Pre-Registration Process Illustrative Order Scheduling & Referral Workflow How We Will Leverage This Technology in Our Operations Auth & Order/ Estimate Schedule Financial Pre-Reg Referral and Pay 1 Transformative Operational Benefits Cle
Slide 13: Solidify and Extend Our Lead as the Most Comprehensive Digital Patient Experience Solution
Solidify and Extend Our Lead as the Most Comprehensive Digital 2 Patient Experience Solution in the Market Technology Requirements The Complete Digital Experience Four Critical Technology Components Required to Chronic Self-Care Guided Search and Schedule Modules Deliver Digital Patient Engagement i
Slide 14: Enable High-Performing Marketplace for Healthcare Services
3 Enable High-Performing Marketplace for Healthcare Services Multi-Sided Marketplace Overview Why R1/SCI are in unique position Match Supply and Demand ▪ Digitizing Scheduling & Order Referral enables efficient matching of qualified demand to supply Referring Health Patients Providers Plans ▪ Scale
Slide 15: R1 Investment Highlights
R1 Investment Highlights 1. Large, Underpenetrated Market 2. Differentiated Value Proposition 3. Multiple Growth & Profit Drivers 4. Strong Financial Trajectory 15
Slide 16: Market Dynamics Play to Our Strengths
Market Dynamics Play to Our Strengths Hospital Implications Need for Market Dynamics for Hospitals Sustainable Solutions ▪ Sub-optimal collections rate ▪ Financial pressures ▪ Weakening margins ▪ Increasing complexity ▪ Infrastructure not delivering ▪ Industry consolidation scale advantages ▪ Capita
Slide 17: Large, Growing and Underpenetrated Market
Large, Growing and Underpenetrated Market $110B RCM Market1 External RCM Spend R1 Revenue Growth Growing Steadily2 $70B Acute-Care $40B Physician $110B Total TAM External TARGET Spend MARKET ~$30B Internal 16% Spend 12% ~$80B CAGR First Quarter 2020 Projected through 2022 year-on-year growth Market
Slide 18: R1 Investment Highlights
R1 Investment Highlights 1. Large, Underpenetrated Market 2. Differentiated Value Proposition 3. Multiple Growth & Profit Drivers 4. Strong Financial Trajectory 18
Slide 19: Comprehensive Transformation
Comprehensive Transformation WORKFLOW PATIENT ACCESS UTILIZATION, CHARGE & CODE CLAIMS & REIMBURSEMENT 1 2 3 4 5 6 7 8 9 10 11 12 13 Phys. Pre-Reg. / Financial Check-in Level of Case Mgmt. Charge Coding & Billing & Denials Customer Patient Pay / Under- Order & Financial Counseling /Arrival Care / Ut
Slide 20: Broad Portfolio of Technology Tools
Broad Portfolio of Technology Tools PATIENT ACCESS & EXPERIENCE YIELD & DENIAL MITIGATION ANALYTICS AUTOMATION Clinical and Scoring and Predictive Technical Personalization Analytics Appeals Actionable Order Integrated Yield-Based Web Service Performance Management Bill Pay Follow-Up Integration Mon
Slide 21: Scalable Infrastructure, Broadest RCM Capabilities
Scalable Infrastructure, Broadest RCM Capabilities High Major end-to-end Scalability Competitors Niche Competitors Low Single-focus Revenue Cycle Capabilities End-to-End 21
Slide 22: R1 Investment Highlights
R1 Investment Highlights 1. Large, Underpenetrated Market 2. Differentiated Value Proposition 3. Multiple Growth & Profit Drivers 4. Strong Financial Trajectory 22
Slide 23: Multi-faceted Approach to Growth
Multi-faceted Approach to Growth Contracted Provides EBITDA growth visibility beyond 2021 Business Rollout Digital Margin expansion through automation and digitizing patient experience Transformation Expansion of Selectively pursue acquisitions and fund internal initiatives Capabilities End-to-end c
Slide 24: Contracted Business Drives Margin Expansion
Contracted Business Drives Margin Expansion End-to-End Customers Deployment Schedule and Margin Progression Penn State Health ($2.2B NPR) Quorum Health, Physician Group1, and RUSH ($4.1B NPR) AMITA and Ascension Medical Group ($6B NPR) Intermountain ($5B NPR) Ascension Phase-2 and Wisconsin ($5B NPR
Slide 25: Digital Transformation Set to Deliver Margin Expansion
Digital Transformation Set to Deliver Margin Expansion 3 Key Levers Year One Results Future Roadmap Automation Center of Excellence developed and Continue to rapidly deploy automations Robotic Process across both new client and new use cases Automation implemented automations resulting in digitizing
Slide 26: R1's Physician Group RCM Capabilities & Scale
R1’s Physician Group RCM Capabilities & Scale Significant $7B+ 30M Scale Net Patient Revenue Patient Encounters Under Management Annually Employed Deep Specialty 27,000+ 80+ and Independent Expertise Providers Specialties Physician Groups Hospital-Based and Office-Based Broad Host System Practice Ca
Slide 27: Well-Positioned to Support Evolution to Value-Based Payments
Well-Positioned to Support Evolution to Value-Based Payments Capability Phase 3 RCM Infrastructure Phase 2 of Choice for VBR Expand RCM Further extend Phase 1 Functionality capabilities to enable partners to take risk and succeed financially Commercialize Value Build or acquire: Proposition to IDNs
Slide 28: R1 Investment Highlights
R1 Investment Highlights 1. Large, Underpenetrated Market 2. Differentiated Value Proposition 3. Multiple Growth & Profit Drivers 4. Strong Financial Trajectory 28
Slide 29: Demonstrated Recurring Revenue Momentum
Demonstrated Recurring Revenue Momentum Quarterly Revenue – $Millions $314M $321M $295 $301M $276 $263 $250 $208 $140 $147 $123 $87 $99 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 Q4'19 Q1'20 29
Slide 30: Appendix
Appendix 30
Slide 31: Contract Economics by Engagement Model
Contract Economics by Engagement Model Illustrative Revenue and EBITDA contribution based on typical $3B NPR Operating Partner Co-Managed Modular $M $M $M 120-150 70-80 30-50 35-45 15-20 10-20 5-15 10-20 3-12 3-12 ~(12) ~(2.0) Year 1 Year 4 Year 1 Year 4 Year 1 Year 4 Revenue contribution EBITDA con
Slide 32: Financial Model for Operating Partner Model
Financial Model for Operating Partner Model Illustrative Contribution from $3B NPR Customer Launch Growth Steady State 0 – 12 Months 12 – 36 Months 36+ Months ▪ Deploy transition resources ▪ Finalize employee transitions ▪ Continuous optimization: ▪ Perform financial ▪ Transfers to Shared Services −
Slide 33: Financial Model for Co-Managed Partner Model
Financial Model for Co-Managed Partner Model Illustrative Contribution from $3B NPR Customer Launch Growth Steady State 0 – 12 Months 12 – 36 Months 36+ Months ▪ Deploy transition resources ▪ Complete standardization ▪ Continuous optimization: ▪ Perform financial ▪ Workflow optimization − KPI metric
Slide 34: Capital Structure
Capital Structure Data as of latest earnings call Cash $107 million in cash and cash equivalents as of 3/31/20 Debt $580 million 169.6 million diluted common shares consisting of: ▪ 114.4 million basic common shares, plus Diluted Common ▪ Dilutive effect of: Shares − Employee stock options − Ascensi